Novel alpha-sulfin and alpha-sulfonamino amide derivatives

[0001] The present invention relates to novel α-sulfin and α-sulfonamino acid amides of formula I below. It relates to the preparation of those substances and to agrochemical compositions comprising at least one of those compounds as active ingredient. The invention relates also to the preparation of the said compositions and to the use of the compounds or of the compositions in controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi.

[0002] The invention relates to α-sulfin- and α-sulfonamino acid amides of the general formula I

[0003] including the optical isomers thereof and mixtures of such isomers,

[0004] wherein

[0005] n is a number zero or one;

[0006] R1 is C1-C12alkyl, C1-C12alkyl substituted with C1-C4alkoxy, C1-C4alkylthio, C1-C4alkylsulfonyl, C3-C8cycloalkyl, cyano, C1-C6alkoxycarbonyl, C3-C8alkenyloxycarbonyl or C3-C6alkynyloxycarbonyl; C3-C8cycloalkyl; C2-C12alkenyl; C2-C12alkynyl; C1-C12halogenalkyl;

[0007] or a group NR9R10 wherein R9 and R10 are each independently of the other hydrogen or C1-C6alkyl, or together are tetra- or penta-methylene;

[0008] R2 and R3 are each independently hydrogen; C1-C8alkyl; C1-C8alkyl substituted with hydroxy, mercapto, C1-C4alkoxy or C1-C4alkylthio: C3-C8alkenyl; C3-C8alkynyl; C3-C8cycloalkyl;

[0009] C3-C8cycloalkyl-C1-C4alkyl; or the two groups R2 and R3 together with the carbon atom to which they are bonded form a three- to eight-membered hydrocarbon ring;

[0010] R4, R5, R6 and R7 are each independently hydrogen or C1-C4alkyl;

[0011] R11, R12, R14, R15 and R17 are each independently hydrogen or C1-C4alkyl,

[0012] R13 is C4-C12alkyl; C1-C12halogenalkyl; C3C8cycloalkyl; optionally substituted aryl or optionally substituted heteroaryl,

[0013] R16 is optionally substituted aryl or optionally substituted heteroaryl, and

[0014] Z is oxygen, sulfur —CR18R19— or —NR20—, wherein R18, R19 and R20 independently of each other are hydrogen or C1-C4alkyl.

[0015] In the above definition aryl includes aromatic hydrocarbon rings like phenyl, naphthyl, anthracenyl, phenanthrenyl, with phenyl being preferred.

[0016] Heteroaryl stands for aromatic ring systems comprising mono-, bi- or tricyclic systems wherein at least one oxygen, nitrogen or sulfur atom is present as a ring member. Examples are furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, indazolyl, benzotriazolyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, phthalazinyl, quinoxalinyl, quinazolinyl, cinnolinyl and naphthyridinyl.

[0017] The above aryl and heteroaryl groups may carry one or more identical or different substituents. Normally not more than three substituents are present at the same time. Examples of substituents of aryl or heteroaryl groups are: alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenyl-alkyl, it being possible in turn for all of the preceding groups to carry one or more identical or different halogen atoms; alkoxy; alkenyloxy; alkynyloxy; alkoxyalkyl; halogenalkoxy, alkylthio; halogenalkylthio; alkyl sulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylamino; dialkyl amino; carboxy; alkoxycarbonyl; alkenyloxycarbonyl; alkynyloxycarbonyl.

[0018] In the above definitions “halogen” or the prefix “halo” includes fluorine, chlorine, bromine and iodine.

[0019] The alkyl, alkenyl and alkynyl radicals may be straight-chain or branched. This applies also to the alkyl, alkenyl or alkynyl parts of other alkyl-, alkenyl- or alkynyl-containing groups.

[0020] Depending upon the number of carbon atoms mentioned, alkyl on its own or as part of another substituent is to be understood as being, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl and the isomers thereof, for example isopropyl, isobutyl, tert-butyl or sec-butyl, isopentyl or tert-pentyl.

[0021] Cycloalkyl is, depending upon the number of carbon atoms mentioned, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.

[0022] Depending upon the number of carbon atoms mentioned, alkenyl as a group or as a structural element of other groups is to be understood as being, for example, ethenyl, allyl, 1-propenyl, buten-2-yl, buten-3-yl, penten-1-yl, penten-3-yl, hexen-1-yl, 4-methyl-3-pentenyl or 4-methyl-3-hexenyl.

[0023] Alkynyl as a group or as a structural element of other groups is, for example, ethynyl, propyn-1-yl, propyn-2-yl, butyn-1-yl, butyn-2-yl, 1-methyl-2-butynyl, hexyn-1-yl, 1-ethyl-2-butynyl or octyn-1-yl.

[0024] A halogenalkyl group may contain one or more (identical or different) halogen atoms, and for example may stand for CHCl2, CH2F, CCl3, CH2Cl, CHF2, CF3, CH2CH2Br, C2Cl5, CH2Br, CHClBr, CF3CH2, etc..

[0025] Where R2 and R3 together with the carbon atom to which they are attached form a hydrocarbon ring the ring corresponds to cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane or cyclooctane.

[0026] Where R9 and R10 together with the nitrogen atom to which they are attached form a ring system the ring corresponds to pyrrolidine or piperidine.

[0027] The presence of at least one asymmetric carbon atom and/or at least one asymmetric oxidized sulfur atom in the compounds of formula I means that the compounds may occur in optically isomeric forms. As a result of the presence of a possible aliphatic C═C double bond, geometric isomerism may also occur. Formula I is intended to include all those possible isomeric forms and mixtures thereof.

[0028] Preferred subgroups of compounds of formula I are those wherein

[0029] n is one; or

[0030] R1 is C1-C12alkyl, C1-C12alkyl substituted with C1-C4alkoxy, C1-C4alkylthio, or C1-C4alkylsulfonyl; C3-C8cycloalkyl; C2-C12alkenyl; C2-C12alkynyl; C1-C12halogenalkyl; or a group NR9R10 wherein R9 and R10 are each independently of the other hydrogen or C1-C6alkyl, or together are tetra- or penta-methylene; or

[0031] R1 is C1-C12alkyl, C2-C12alkenyl; C1-C12halogenalkyl; or a group NR9R10 wherein R9 and R10 are each independently of the other hydrogen or C1-C6alkyl; or

[0032] R1 is C1-C4alkyl, C2-C4alkenyl; C1-C4halogenalkyl; or C1-C2dialkylamino; or

[0033] R1 is C1-C4alkyl, vinyl; C1-C4halogenalkyl; or dimethylamino; or

[0034] R2 is hydrogen and R3 is C1-C8alkyl, C1-C8alkyl optionally substituted by hydroxy, C1-C4-alkoxy, mercapto or C1-C4alkylthio; C3-C8alkenyl; C3-C8alkynyl; C3-C8cycloalkyl or C3-C8cycloalkyl-C1-C4alkyl; or

[0035] R2 is hydrogen and R3 is C1-C4alkyl; C3-C4alkenyl or cyclopropyl; or

[0036] R2 is hydrogen and R3 is C3-C4alkyl; allyl or cyclopropyl; or

[0037] R2 is hydrogen and R3 is isopropyl; or

[0038] R4 is hydrogen, methyl or ethyl; or

[0039] R4 is hydrogen or methyl; or

[0040] R4 is hydrogen; or

[0041] R5, R6 and R7 are each independently hydrogen or methyl; or

[0042] R5, R6 and R7 are each hydrogen; or

[0043] R11, R12, R14, R15 and R17 are each independently hydrogen or methyl; or

[0044] R11, R12, R14, R15 and R17 are each hydrogen; or

[0045] R,3 is C4-C12alkyl; C1-C12halogenalkyl; C3-C8cycloalkyl; optionally substituted aryl or optionally substituted heteroaryl consisting of one or two condensed five or six membered rings with 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur; or

[0046] R13 is C4-C12alkyl; C1-C12halogenalkyl; C3-C8cycloalkyl; phenyl, naphthyl, furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, benzthiazolyl, benzoxazolyl or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-C1-C4alkyl, phenyl, phenyl-C1-C4alkyl wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms; C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C1-C8alkoxy-C1-C4alkyl, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, C1-C8alkylsulfonyl, formyl, C2-C8alkanoyl, hydroxy, halogen, cyano, nitro, amino and C1-C8alkylamino, C1-C8dialkylamino, carboxy, C1-C8alkoxycarbonyl, C1-C8alkenyloxycarbonyl and C1-C8alkynyloxycarbonyl; or

[0047] R13 is C4-C12alkyl; C1-C1-halogenalkyl; C3-C8cycloalkyl; phenyl, naphthyl, thienyl, pyridyl, pyrimidinyl, triazinyl, or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8-alkyl, C2-C8alkenyl, wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms; C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C1-C8alkoxycarbonyl; or

[0048] R13 is C4-C8alkyl; C1-C6halogenalkyl; C3-C8cycloalkyl; phenyl, pyridyl, with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C1-C8halogenalkyl, C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C1-C8alkoxycarbonyl; or

[0049] R16 is optionally substituted aryl or optionally substituted heteroaryl consisting of one or two condensed five or six membered rings with 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur; or

[0050] R16 is phenyl, naphthyl, furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, benzthiazolyl, benzoxazolyl or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8-cycloalkyl, C3-C8cycloalkyl-C1-C4alkyl, phenyl, phenyl-C1-C4alkyl wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms; C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C1-C8alkoxy-C1-C4alkyl, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, C1-C8alkylsulfonyl, formyl, C2-C8alkanoyl, hydroxy, halogen, cyano, nitro, amino, C1-C8alkylamino, C1-C8dialkylamino, carboxy, C1-C8alkoxycarbonyl, C1-C8alkenyloxycarbonyl and C1-C8alkynyloxycarbonyl; or

[0051] R16 is phenyl, naphthyl, thienyl, pyridyl, pyrimidinyl, triazinyl, or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8alkenyl, wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms; C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C1-C8alkoxycarbonyl; or

[0052] R16 is phenyl, pyridyl, with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C1-C8halogenalkyl, C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8-halogenalkylthio, halogen, cyano, nitro and C1-C8alkoxycarbonyl; or

[0053] Z is oxygen, sulfur or —CH2—; or

[0054] Z is oxygen.

[0055] Further preferred subgroups of the compounds of formula I are those wherein

[0056] 1) R1 is C1-C12alkyl, C1-C12alkyl substituted with C1-C4alkoxy, C1-C4alkylthio, or C1-C4alkylsulfonyl; C3-C8cycloalkyl; C2-C12alkenyl; C2-C12alkynyl; C1-C12halogenalkyl; or a group NR9R10 wherein R9 and R10 are each independently of the other hydrogen or C1-C6alkyl, or together are tetra- or penta-methylene;

[0057] R2 is hydrogen and R3 is C1-C8alkyl; C1-C8alkyl substituted with hydroxy, mercapto, C1-C4alkoxy or C1-C4alkylthio; C3-C8alkenyl; C3-C8alkynyl; C3-C8cycloalkyl; C3-C8cycloalkyl-C1-C4alkyl;

[0058] R13 is C4-C12-alkyl; C1-C12-halogenalkyl; C3-C8cycloalkyl; optionally substituted aryl or optionally substituted heteroaryl consisting of one or two condensed five or six membered rings with 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur; and

[0059] R16 is optionally substituted aryl or optionally substituted heteroaryl consisting of one or two condensed five or six membered rings with 1 to 4 identical or different heteroatoms selected from oxygen, nitrogen or sulfur; or

[0060] 2) n is one;

[0061] R1 is C1-C12alkyl, C2-C12alkenyl; C1-C12halogenalkyl; or a group NR9R10 wherein R9 and R10 are each independently of the other hydrogen or C1-C6alkyl;

[0062] R2 is hydrogen and R3 is C1-C4alkyl; C3-C4alkenyl or cyclopropyl;

[0063] R4 is hydrogen, methyl or ethyl; or

[0064] R5, R6, R7, R11, R12, R14, R15 and R17 are each independently hydrogen or methyl;

[0065] R13 is C4-C12alkyl; C1-C12-halogenalkyl; C3-C8-cycloalkyl; phenyl, naphthyl, furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, benzthiazolyl, benzoxazolyl or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl -C1-C4alkyl, phenyl, phenyl-C1-C4alkyl wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms; C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C1-C8alkoxy-C1-C4alkyl, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, C1-C8alkylsulfonyl, formyl, C2-C8alkanoyl, hydroxy, halogen, cyano, nitro, amino and C1-C8alkylamino, C1-C8-dialkylamino, carboxy, C1-C8-alkoxycarbonyl, C1-C8-alkenyloxycarbonyl and C1-C8alkynyloxycarbonyl;

[0066] R16 is phenyl, naphthyl, furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, benzthiazolyl, benzoxazolyl or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8-alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl-C1-C4alkyl, phenyl, phenyl-C1-C4alkyl wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms; C1-C8alkoxy, C3-C8alkenyloxy, C3-C8alkynyloxy, C1-C8alkoxy-C1-C4alkyl, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, C1-C8alkylsulfonyl, formyl, C2-C8alkanoyl, hydroxy, halogen, cyano, nitro, amino and C1-C8alkylamino, C1-C8dialkylamino, carboxy, C1-C8alkoxycarbonyl, C1-C8alkenyloxycarbonyl and C1-C8alkynyloxycarbonyl; and

[0067] Z is oxygen, sulfur or —CH2—; or

[0068] 3) n is one;

[0069] R1 is C1-C4alkyl, C2-C4alkenyl; C1-C4halogenalkyl; or C1-C2-dialkylamino;

[0070] R2 is hydrogen and R3 is C3-C4alkyl; allyl or cyclopropyl;

[0071] R4 is hydrogen or methyl;

[0072] R5, R6, R7, R11, R12, R14, R15 and R17 are each hydrogen;

[0073] R13 is C4-C12alkyl; C1-C12halogenalkyl; C3-C8cycloalkyl; phenyl, naphthyl, thienyl, pyridyl, pyrimidinyl, triazinyl, or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8alkenyl, wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms; C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C1-Calkoxycarbonyl;

[0074] R16 is phenyl, naphthyl, thienyl, pyridyl, pyrimidinyl, triazinyl, or quinolyl with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C2-C8alkenyl, wherein the hydrogens of all these substituents may be optionally substituted by one or more identical or different halogen atoms; C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C1-C8alkoxycarbonyl; and

[0075] Z is oxygen, sulfur or —CH2—; or

[0076] 4) n is one;

[0077] R1 is C1-C4alkyl, vinyl; C1-C4halogenalkyl; or dimethylamino;

[0078] R2 is hydrogen and R3 is isopropyl;

[0079] R4, R5, R6, R7, R11, R12, R14, R15 and R17 are each hydrogen;

[0080] R13 is C4-C8alkyl; C1-C6halogenalkyl; C3-C8cycloalkyl; phenyl, pyridyl, with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C1-C8halogenalkyl, C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8-halogenalkylthio, halogen, cyano, nitro and C1-C8alkoxycarbonyl;

[0081] R16 is phenyl, pyridyl, with each of the aromatic ring being optionally substituted by 1 to 3 substituents selected from the group consisting of C1-C8alkyl, C1-C8halogenalkyl, C1-C8alkoxy, C1-C8halogenalkoxy, C1-C8alkylthio, C1-C8halogenalkylthio, halogen, cyano, nitro and C1-C8alkoxycarbonyl; and

[0082] Z is oxygen.

[0083] Preferred individual compounds are:

[0084] N-(2-{4-[3-(4-chloro-phenyl)-prop-2-ynyloxy]-phenyl}-ethyl)-2-methanesulfonylamino-3-methyl-butyramide,

[0085] N-(2-{4-[3-(4-fluoro-phenyl)-prop-2-ynyloxy]-phenyl}-ethyl)-2-methanesulfonylamino-3-methyl-butyramide,

[0086] N-(2-{4-[3-(4-bromo-phenyl)-prop-2-ynyloxy]-phenyl}-ethyl)-2-methanesulfonylamino-3-methyl-butyramide,

[0087] N-(2-{4-[3-(p-tolyl)-prop-2-ynyloxy]-phenyl}-ethyl)-2-methanesulfonylamino-3-methyl-butyramide,

[0088] N-{2-[4-(3-cyclopropyl-prop-2-ynyloxy)-phenyl]-ethyl}-2-methanesulfonylamino-3-methyl-butyramide,

[0089] N-(2-{4-[3-(4-chloro-phenyl)-prop-2-ynyloxy]-phenyl}-ethyl)-2-ethanesulfonylamino-3-methyl-butyramide,

[0090] N-(2-{4-[3-(4-fluoro-phenyl)-prop-2-ynyloxy]-phenyl)-ethyl}-2-ethanesulfonylamino-3-methyl-butyramide,

[0091] N-(2-{4-[3-(4-bromo-phenyl)-prop-2-ynyloxy]-phenyl}-ethyl)-2-ethanesulfonylamino-3-methyl-butyramide,

[0092] N-(2-{4-[3-(p-tolyl)-prop-2-ynyloxy]-phenyl}-ethyl)-2-ethanesulfonylamino-3-methyl-butyramide, and

[0093] N-{2-[4-(3-cyclopropyl-prop-2-ynyloxy)-phenyl]-ethyl}-2-ethanesulfonylamino-3-methyl-butyramide.

[0094] Certain α-sulfin- and α-sulfonamino acid derivatives having a different kind of molecular structure have already been proposed for controlling plant-destructive fungi (for example in WO 95/030651, WO 97/14677, WO 98/38160, WO 98/38161 and WO 99/07674).

[0095] However, the activity of the known compounds is not always satisfactory in all aspects of agricultural needs. Surprisingly, with the compound structure of formula I, a new kind of microbiocides have been found showing an improved systemic activity in plants against phytopathogenic microorganisms, especially fungi.

[0096] The α-sulfin- and α-sulfonamino acid amides of formula I may be obtained according to one of the following processes:

[0097] a)

[0098] An amino acid of formula II or a carboxy-activated derivative of an amino acid of formula II wherein R1, n, R2 and R3 are as defined for formula I is reacted with an amine of formula III wherein R4, R5, R6, R7 and R8 are as defined above optionally in the presence of a base and optionally in the presence of a diluting agent (step B).

[0099] Carboxy-activated derivatives of the amino acid of formula II encompasses all compounds having an activated carboxyl group like an acid halide, such as an acid chloride, like symmetrical or mixed anhydrides, such as mixed anhydrides with O-alkylcarbonates, like activated esters, such as p-nitrophenylesters or N-hydroxysuccinimidesters, as well as in situ produced activated forms of the amino acid of formula II by condensating agents, such as dicyclohexylcarbodiimide, carbonyldiimidazol, benzotriazol-1-yloxy-tris (dimethylamino)phosphonium hexafluorophosphate, O-benzotriazol-1-yl N,N,N′,N′-bis(penta methylene)uronium hexafluorophosphate, O-benzotriazol-1-yl N,N,N′,N′-bis(tetramethylene)uronium hexafluorophosphate, O-benzotriazol-1-yl N,N,N′,N′-tetramethyluronium hexafluorophosphate or benzotriazol-1-yloxy-tripyrrolidino phosphonium hexafluorophosphate. The mixed anhydrides of the amino acids of the formula II may be prepared by reaction of an amino acid of formula II with chloroformic acid esters like chloroformic acid alkylesters, such as ethyl chloroformate or isobutyl chloroformate, optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethylamine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine.

[0100] The present reaction is preferably performed in an inert solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e.g. dichloromethane or toluene; ketones, e.g. acetone; esters, e.g. ethyl acetate; amides, e.g. N,N -dimethylformamide; nitriles e.g. acetonitrile; or ethers e.g. diethylether, tert-butyl-methylether, dioxane or tetrahydrofurane or water. It is also possible to use mixtures of these solvents.

[0101] The reaction is preformed optionally in the presence of an organic or inorganic base like a tertiary amine, e.g. triethylamine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine, like a metal hydroxide or a metal carbonate, preferentially an alkali hydroxide or an alkali carbonate, such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures ranging from −80° C. to +150° C., preferentially at temperatures ranging from −40° C. to +40° C.

[0102] The compounds of formula II may be prepared by reaction of an amino acid of formula IV where R2 and R3 are as defined for formula I with a sulfonyl halide or a sulfinyl halide of formula V where R1 and n have the same meanings as defined above and where X is halide, preferentially chlorine or bromine (step A).

[0103] The reaction may be performed in an inert solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons, e.g. dichloromethane or toluene; ketones, e.g. acetone; esters, e.g. ethyl acetate; ethers, e.g. diethylether, tert-butyl-methylether, dioxane or tetrahydrofurane or water. It is also possible to use mixtures of these solvents. The reaction is performed optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethylamine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine, like a metal hydroxide or a metal carbonate, preferentially an alkali hydroxide or an alkali carbonate, such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures ranging from −80° C. to +150° C., preferentially at temperatures ranging from −40° C. to +40° C.

[0104] b)

[0105] The compounds of formula I may also be prepared by reaction of an amino acid derivative of formula VI wherein R2, R3, R4, R5, R6, R7 and R8 are as defined for formula I with a sulfonyl halide or a sulfinyl halide of formula V wherein R1 and n are as defined for formula I and X is halide, preferentially chlorine or bromine (step C). The reaction is performed in the same manner as described for step A.

[0106] c)

[0107] The compounds of formula I may also be prepared by reaction of a phenol of formula VII wherein R1, n, R2, R3, R4, R5, R6 and R7 are as defined for formula I with a compound of formula VIII wherein R8 is as defined for formula I and Y is a leaving group like a halide such as a chloride or bromide or a sulfonic ester such as a tosylate, mesylate or triflate (step D).

[0108] The reaction may be performed in an inert solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e.g. dichloromethane or toluene; ketones e.g. acetone or 2-butanone; esters, e.g. ethyl acetate; ethers, e.g. diethylether, tert-butyl-methylether, dioxane or tetrahydrofurane, amides, e.g. dimethylformamide, nitriles, e.g. acetonitrile, alcohols, e.g. methanol, ethanol, isopropanol, n-butanol or tert-butanol, sulfoxides e.g. dimethylsulfoxide or water. It is also possible to use mixtures of these solvents. The reaction is performed optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethylamine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine, like a metal hydroxide, a metal carbonate or a metal alkoxide, preferentially an alkali hydroxide, an alkali carbonate or an alkali alkoxide, such as lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, sodium tert-butoxide or potassium tert-butoxide at temperatures ranging from −80° C. to +200° C., preferentially at temperatures ranging from 0° C. to +120° C.

[0109] d)

[0110] The compounds of formula la may also be prepared via formula IX wherein R1, n, R2, R3, R4, R5, R6, R7, R11, R12 and R13 are defined for formula I by reacting of a phenol of formula VII wherein R1, n, R2, R3, R4, R5 R6 and R7 are as defined for formula I with a compound of formula VIIIa wherein R11, R12 and R13 are as defined for formula I and Y is a leaving group like a halide such as a chloride or bromide or a sulfonic ester such as a tosylate, mesylate or triflate (step E).

[0111] The reaction is performed in the same manner as described for step D.

[0112] The compounds of formula Ia R11, R12 and R13 is as defined for formula I may be prepared by reaction of compounds of formula IX with hydrogen.

[0113] The reaction is performed in a solvent like ethers, e.g. diethylether, dioxane or tetrahydrofuran, or like alcohols, e.g. methanol or ethanol, or water in the presence of transition metals or transition metal salts, e.g. nickel, cobalt, palladium, platinum or rhodium, optionally in the presence of bases, e.g. ammonia, or in the presence of salts, e.g. barium sulfate, at temperatures ranging from −20° C. to +160° C. and at pressures ranging from 1 to 200 bar.

[0114] aa) The intermediate amines of formula Ill may be obtained by one of the following processes:

[0115] Step 1 is the alkylation of a phenol with a compound of formula VIII. The reaction is performed in the same manner as described for procedure c).

[0116] Step 2 is the reaction of an aromatic aldehyde with nitromethane. This reaction is performed in a solvent like an organic carboxylic acids, e.g. acetic acid optionally in the presence of the ammonium salt of this carboxylic acid, e.g. ammonium acetate at temperatures ranging from 0° C. to +200° C.

[0117] Step 3 is the reduction of an unsaturated nitrogen-compound. This reaction is performed in a solvent like an ether, e.g. diethylether, dioxane or tetrahydrofuran, or an alcohol, e.g. methanol, ethanol or isopropanol, with borohydride, with a boron-complex, e.g. the complex of borohydride with tetrahyrofuran, with an alkaliborohydride, with an alkalialuminiumhydride, e.g. lithiumaluminiumhydride, with aluminiumhydride, with an aluminiumalkoxyhydride or with hydrogen optionally in the presence of a transition metal, a transition metal salt or a transition metal complex, e.g. nickel, cobalt, palladium, platinium or rhodium at temperatures ranging from −50° C. to +200° C.

[0118] Step 4 is the reaction of an aldehyde or a ketone of formula XXIII with hydroxylamine or with a salt of hydroxylamine. This reaction is performed in a solvent like an alcohol, e.g. methanol, ethanol or isopropanol, like an ether, e.g. diethylether, dioxane or tetrahydrofuran, like an amide, e.g. dimethylformamide, or in water or in a mixture of these solvents optionally in the presence of an organic or inorganic base like a tertiary amine, e.g. triethylamine, like a heterocyclic compound containing nitrogen, e.g. pyridine, or like an alkalicarbonate, e.g. sodium carbonate or potassium carbonate, at temperatures ranging from −20° C. to +150° C.

[0119] Step 5 is the exchange of hydroxy by cyanide. This reaction is performed in an organic solvent like an amide, e.g. dimethylformamide using a metal cyanide like an alkali cyanide, e.g. sodium cyanide or potassium cyanide, at temperatures ranging from 0° C. to +200° C.

[0120] Step 6 is the hydrolysis of an alkyl ester. This reaction is performed in a solvent like an alcohol, e.g. methanol, ethanol or isopropanol, like an ether, e.g. diethylether, dioxane or tetrahydrofuran, like a halogenated hydrocarbon, e.g. dichloromethane, or water or in a mixture of these solvents optionally in the presence of an alkali hydroxide, e.g. lithium hydroxide, sodium hydroxide or potassium hydroxide, or optionally in the presence of an acid, e.g. hydrogen chloride, sulfuric acid or trifluoroacetic acid at temperatures ranging from −20° C. to +160° C.

[0121] Step 7 is the reaction of a carboxylic acid or the activated form of this carboxylic acid with hydrogen azide or an azide-salt. An activated form of a carboxylic acid can be the acid halogenide, e.g. acid chloride, a symmetric or a mixed anhydride. Azide-salts can be alkali azides, e.g. sodium azide. The reaction is performed in a solvent like a hydrocarbon, e.g. toluene or xylene, like a halogenated hydrocarbon, e.g. chloroform, like an ether, e.g. dioxane, like a ketone, e.g. acetone or 2-butanone, like an alcohol, e.g. methanol, ethanol or tert-butanol, or water or in a mixture of these solvents optionally in the presence of an acid like an inorganic acid, e.g. sulfuric acid or hydrogen chloride at temperatures ranging from −40° C. to +200° C.

[0122] In a preferred form the compounds of formula XXVI are prepared starting from compounds of the formula XXV by applying step 5 and step 1 in the same pot.

[0123] bb) Amines of formula VI can be obtained by the following process:

[0124] wherein R is lower alkyl or optionally substituted benzyl.

[0125] Step 8 is the amidation of an carbamate-protected amino acid of formula XXXIII with an amine of formula XXXIV. The reaction is performed in the same manner as described for step A.

[0126] Step 9 is the alkylation of a phenol of formula XXXV with an compound of formula VIII. The reaction is performed in the same manner as described for step D.

[0127] Step 10 is the hydrolysis of a carbamate of formula XXXVI. The reaction is performed in a solvent like hydrocarbons, e.g. toluene, like halogenated hydrocarbons, e.g. dichloromethane, like ketones, e.g. acetone, like esters, e.g. ethyl acetate, like ethers, e.g. dioxane or tetrahydrofuran, or like water or in mixtures of these solvents optionally in the presence of an organic acid like carboxylic acid, e.g. trifluoroacetic acid, or like a sulfonic acid, e.g. methanesulfonic acid or toluenesulfonic acid, or in the presence of an inorganic acid, e.g. hydrogen chloride or sulfuric acid, at temperatures ranging from −40° C. to +160° C.

[0128] The compounds of formula I are oils or solids at room temperature and are distinguished by valuable microbiocidal properties. They can be used in the agricultural sector or related technical fields preventively and curatively for the control of plant-destructive microorganisms. The compounds of formula I according to the invention are distinguished at low rates of concentration not only by outstanding microbiocidal, especially fungicida l, activity but also by being especially well tolerated by the treated crop plants.

[0129] Surprisingly, it has now been found that for practical purposes the compounds of formula I have a very advantageous biocidal spectrum in the control of phytopathogenic microorganisms, especially fungi. With the compounds of formula I it is possible to inhibit or destroy phytopathogenic microorganisms that occur on various crops of useful plants or on parts of such plants (fruit, blossom, leaves, stems, tubers, roots), while parts of the plants which grow later also remain protected, for example, against phyto pathogenic fungi.

[0130] The novel compounds of formula I prove to be effective against specific genera of the fungus classes Fungi imperfecti (e.g. Cercospora), Basidio mycetes (e.g. Puccinia) and Ascomycetes (e.g. Erysiphe and Venturia) and especially against Oomycetes (e.g. Plasmopara. Peronospora, Pythium and Phytophthora). They therefore represent in plant protection a valuable addition to the compositions for controlling phyto pathogenic fungi. The compounds of formula I can also be used as coatings or dressings for protecting seed (fruit, tubers, grains) and plant cuttings from fungal infections and against phyto pathogenic fungi that occur in the soil.

[0131] The invention relates also to compositions comprising compounds of formula I as active ingredient, especially plant-protecting compositions, and to the use thereof in the agricultural sector or related fields.

[0132] In addition, the present invention includes the preparation of those compositions, wherein the active ingredient is homogeneously mixed with one or more of the substances or groups of substances described herein. Also included is a method of treating plants which is distinguished by the application of the novel compounds of formula I or of the novel compositions.

[0133] Target crops to be protected within the scope of this invention comprise, for example, the following species of plants: cereals (wheat, barley, rye, oats, rice, maize, sorghum and related species); beet (sugar beet and fodder beet); pomes, stone fruit and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); leguminous plants (beans, lentils, peas, soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans, groundnuts); cucurbitaceae (marrows, cucumbers, melons); fibre plants (cotton, flax, hemp, jute); citrus fruit (oranges, lemons, grapefruit, mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, paprika); lauraceae (avocado, cinnamon, camphor) and plants such as tobacco, nuts, coffee, sugar cane, tea, pepper, vines, hops, bananas and natural rubber plants, and also ornamentals.

[0134] The compounds of formula I are normally used in the form of compositions and can be applied to the area or plant to be treated simultaneously or in succession with other active ingredients. Those other active ingredients may be fertilisers, micronutrient donors or other preparations that influence plant growth. It is also possible to use selective herbicides or insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of those preparations, if desired together with further carriers, surfactants or other application-promoting adjuvants customarily employed in formulation technology.

[0135] The compounds of formula I can be mixed with other fungicides, resulting in some cases in unexpected synergistic activities.

[0136] Mixing components which are particularly preferred are azoles such as azoles, such as azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, pefurazoate, penconazole, pyrifenox, prochloraz, propiconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole, triticonazole; pyrimidinyl carbinols, such as ancymidol, fenarimol, nuarimol; 2-amino-pyrimidines, such as bupirimate, dimethirimol, ethirimol; morpholines, such as dodemorph, fenpropidine, fenpropimorph, spiroxamine, tridemorph; anilinopyrimidines, such as cyprodinil, mepanipyrim, pyrimethanil; pyrroles, such as fenpiclonil, fludioxonil; phenylamides, such as benalaxyl, furalaxyl, metalaxyl, R-metalaxyl, ofurace, oxadixyl; benzimidazoles, such as benomyl, carbendazim, debacarb, fuberidazole, thiabendazole; dicarboximides, such as chlozolinate, dichlozoline, iprodione, myclozoline, procymidone, vinclozolin; carboxamides, such as carboxin, fenfuram, flutolanil, mepronil, oxycarboxin, thifluzamide; guanidines, such as guazatine, dodine, iminoctadine; strobilurines, such as azoxystrobin, kresoxim-methyl, metominostrobin, SSF-129, CGA 279202 (trifloxystrobin), picoxystrobin; dithiocarbamates, such as ferbam, mancozeb, maneb, metiram, propineb, thiram, zineb, ziram; N-halogenmethylthiophthalimides, such as captafol, captan, dichlofluanid, fluoromide, folpet, tolyfluanid; Cu compounds, such as Bordeaux mixture, copper hydroxide, copper oxychloride, copper sulfate, cuprous oxide, mancopper, oxine-copper; nitrophenol derivatives, such as dinocap, nitrothal-isopropyl; organo-P derivatives, such as edifenphos, iprobenphos, isoprothiolane, phosdiphen, pyrazophos, tolclofos-methyl; various, such as AC382042, acibenzolar-S-methyl, anilazine, blasticidin-S, quinomethionat, chloroneb, chlorothalonil, cymoxanil, dichlone, diclomezine, dicloran, diethofencarb, dimethomorph, dithianon, etridiazole, famoxadone, fenamidone, fenhexamid, fentin, ferimzone, fluazinam, flusulfamide, fosetyl-aluminium, hymexazol, IKF-916, iprovalicarb, kasugamycin, methasulfocarb, MON65500, pencycuron, phthalide, polyoxins, probenazole, propamocarb, pyroquilon, quinoxyfen, quintozene, RH-7281, RPA 407213, BAS 50001 F, sulfur, SYP-Z071, triazoxide, tricyclazole, triforine, validamycin.

[0137] Suitable carriers and surfactants may be solid or liquid and correspond to the substances ordinarily employed in formulation technology, such as e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilisers. Such carriers and additives are described, for example, in WO 95/30651.

[0138] A preferred method of applying a compound of formula I, or an agrochemical composition comprising at least one of those compounds, is application to the foliage (foliar application), the frequency and the rate of application depending upon the risk of infesta tion by the pathogen in question. The compounds of formula I may also be applied to seed grains (coating) either by impregnating the grains with a liquid formulation of the active ingredient or by coating them with a solid formulation.

[0139] The compounds of formula I are used in unmodified form or, preferably, together with the adjuvants conventionally employed in formulation technology, and are for that purpose advantageously formulated in known manner e.g. into emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granules, and by encapsulation in e.g. polymer substances. As with the nature of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances.

[0140] Advantageous rates of application are normally from 1 g to 2 kg of active ingredient (a.i.) per hectare (ha), preferably from 10 g to 1 kg a.i./ha, especially from 25 g to 750 g a.i./ha. When used as seed dressings, rates of from 0.001 g to 1.0 g of active ingredient per kg of seed are advantageously used.

[0141] The formulations, i.e. the compositions, preparations or mixtures comprising the compound(s) (active ingredient(s)) of formula I and, where appropriate, a solid or liquid adjuvant, are prepared in known manner, e.g. by homogen eously mixing and/or grinding the active ingredient with extenders, e.g. solvents, solid carriers and, where appropriate, surface-active compounds (surfactants).

[0142] Further surfactants customarily used in formulation technology will be known to the person skilled in the art or can be found in the relevant technical literature.

[0143] The agrochemical compositions usually comprise 0.01 to 99 % by weight, preferably 0.1 to 95% by weight, of a compound of formula I, 99.99 to 1% by weight, preferably 99.9 to 5% by weight, of a solid or liquid adjuvant, and 0 to 25% by weight, preferably 0.1 to 25% by weight, of a surfactant.

[0144] Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations.

[0145] The compositions may also comprise further ingredients, such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as fertilisers or other active ingredients for obtaining special effects.

[0146] The Examples which follow illustrate the invention described above, without limiting the scope thereof in any way. Temperatures are given in degrees Celsius.

PREPARATION EXAMPLES FOR COMPOUNDS OF FORMULA I

Example A1.1

(S)-2-Ethanesulfonylamino-N-(2-{4-[3-(4-chloro-phenyl)-propargyloxvy]-phenyl}-ethyl)-3-methyl-butyramide

[0147]

[0148] A mixture of 1.0 g of (S)-2-ethanesulfonylamino-N-[2-(4-hydroxy-phenyl)-ethyl]-3-methyl-butyramide, 1.3 g of toluene-4-sulfonic acid 3-(4-chloro-phenyl)-prop-2-ynyl ester and 4.9 ml of a 1M solution of sodium methoxide in methanol in 25 ml of methanol is heated to reflux for 2 hours. After cooling 200 ml of water is added. The mixture is extracted with ethyl acetate (2×300 ml). The organic layers are washed with brine (2×100 ml), combined, dried (MgSO4) and evaporated. (S)-N-(2-{4-[3-(4-Chloro-phenyl)-propargyloxy]-phenyl}-ethyl) -2-ethanesulfonylamino-3-methyl-butyramide is obtained which is purified by recrystallization (ethyl acetate/hexane), m.p. 141-142° C.

[0149] Analogously to example A1.1 the compounds listed in table A1 are obtained.

[0150] *) Configuration on the α-C-atom in the amino acid moiety; Ph means phenyl

1TABLE A1

NoR1*)R3R4R8m.p. (° C.)A1.1CH3—CH2—(S)(CH3)2CH—H(4-Cl-Ph)-C≡C—CH2—141-142A1.2CH3—CH2—(S)(CH3)2CH—H(4-F-Ph)-C≡C—CH2—133-134A1.3CH3(S)(CH3)2CH—H(4-Cl-Ph)-C≡C—CH2—154-155A1.4CH3(S)(CH3)2CH—H(4-F-Ph)-C≡C—CH2—104-105A1.5CH3(S)(CH3)2CH—H(4-Br-Ph)-C≡C—CH2—161-164A1.6CH3(S)(CH3)2CH—H(4-CH3-Ph)-C≡C—CH2—110-112A1.7CH3(S)(CH3)2CH—H(4-Cl-Ph)-CH═CH—CH2—144-145A1.8CH3(S)(CH3)2CH—H(4-Cl-Ph)-CH2—CH2—CH2—176-177A1.9CH3(S)(CH3)2CH—H(3-CF3-Ph)-CH2147-153

Example A2.1

(S)-2-Ethanesulfonylamino-N-[2-(4-hydroxy-phenyl)-ethyl]-3-methyl-butyramide

[0151]

[0152] 18.6 g of (S)-N-[2-(4-benzyloxy-phenyl)-ethyl]-2-ethanesulfonylamino-3-methyl-butyramide and 16.8 g of palladium (5% on charcoal) in 400 ml of tetrahydrofuran are shaken under a hydrogen atmosphere at +30 to +−35° C. and at normal pressure for 5 hours. The reaction mixture is filtered and evaporated. (S)-2-ethanesulfonylamino-N-[2-(4-hydroxy-phenyl)ethyl)-]-3-methyl-butyramide is obtained in form of an oil [MS (m/e): 329 (M+H)+].

[0153] Analogously to example A2.1 the compounds listed in table A2 are obtained.

[0154] *) Configuration on the α-C-atom in the amino acid moiety; Ph means phenyl

2TABLE A2

NoR1*)R3R4m.p. (° C.)A2.1CH3—CH2—(S)(CH3)2CH—HOilA2.2CH3(S)(CH3)2CH—H120-121*) Configuration of the amino acid moiety

Example A3.1

(S)-N-[2-(4-Benzyloxy-phenyl)-ethyl]-2-ethanesulfonylamino-3-methyl-butyramide

[0155]

[0156] 15 g of (S)-2-ethanesulfonylamino-3-methyl-butyric acid, 10.3 g of thionyl chloride and N,N-dimethylformamide (2 drops) in toluene (75 ml) are refluxed for 2 hours. The solvent is then evaporated. To the resulting residue 100 ml of toluene is added. The mixture is then evaporated to dryness again. The residue is dissolved in dioxane (100 ml) and added to a mixture of 2-(4-benzyloxy-phenyl)-ethylamine (15.3 g) and triethylamine (7.2 g) in dioxane (100 ml). The reaction mixture is stirred at room temperature over night. Water (400 ml) is added. It is extracted with ethyl acetate (2×500 ml). The organic layers are washed with hydrochloric acid (80 ml, 1M solution) and brine (2×100 ml), dried (MgSO4) and evaporated. (S)-N-[2-(4-Benzyloxy-phenyl)-ethyl]-2-ethanesulfonylamino-3-methyl-butyramide which is purified by recrystallization (ethyl acetate/hexane), m.p. 133-134° C.

[0157] Analogously to example A3.1 the compounds listed in table A3 are obtained.

[0158] *) Configuration on the α-C-atom in the amino acid moiety; Ph means phenyl

3TABLE A3

NoR1*)R3R4m.p. (° C.)A3.1CH3—CH2—(S)(CH3)2CH—H133-134A3.2CH3(S)(CH3)2CH—H153-154*) Configuration of the amino acid moiety

[0159] Analogously to the above Examples the following compounds of Tables 1 to 13 may be prepared. In the tables Ph means phenyl.

4TABLE 1Compounds represented by the Formula 1.1 where the combinationof the groups R1, R3 and R8 correspondsto each row in table A.I.1

[0160]

5

TABLE 2

Compounds represented by the Formula 1.2 where the combination

of the groups R1, R3 and R8 corresponds

to each row in table A.

I.2

[0161]

6

TABLE 3

Compounds represented by the Formula 1.3 where the combination

of the groups R1, R3 and R8 corresponds

to each row in table A.

I.3

[0162]

7

TABLE 4

Compounds represented by the Formula 1.4 where the combination

of the groups R1, R3 and R8 corresponds

to each row in table A.

I.4

[0163]

8

TABLE 5

Compounds represented by the Formula 1.5 where the combination

of the groups R1, R3 and R8 corresponds

to each row in table A.

I.5

[0164]

9

TABLE 6

Compounds represented by the Formula I.6 where the combination

of the groups R1, R3 and R8 corresponds to each

row in table A.

I.6

[0165]

10

TABLE A

No.
R1
R3
R8

001
CH3—
CH3—CH2—
CH3—(CH2)3—C≡C—CH2—

002
CH3—CH2—
CH3—CH2—
CH3—(CH2)3—C≡C—CH2—

003
(CH3)2N—
CH3—CH2—
CH3—(CH2)3—C≡C—CH2—

004
CH3—CH2—CH2—
CH3—CH2—
CH3—(CH2)3—C≡C—CH2—

005
(CH3)2CH—
CH3—CH2—
CH3—(CH2)3—C≡C—CH2—

006
Cl—CH2—CH2—CH2—
CH3—CH2—
CH3—(CH2)3—C≡C—CH2—

007
CH3—
(CH3)2CH—
CH3—(CH2)3—C≡C—CH2—

008
CH3—CH2—
(CH3)2CH—
CH3—(CH2)3—C≡C—CH2—

009
(CH3)2N—
(CH3)2CH—
CH3—(CH2)3—C≡C—CH2—

010
CH3—CH2—CH2—
(CH3)2CH—
CH3—(CH2)3—C≡C—CH2—

011
(CH3)2CH—
(CH3)2CH—
CH3—(CH2)3—C≡C—CH2—

012
Cl—CH2—CH2—CH2—
(CH3)2CH—
CH3—(CH2)3—C≡C—CH2—

013
CH3—
CH3—CH2—CH2—
CH3—(CH2)3—C≡C—CH2—

014
CH3—CH2—
CH3—CH2—CH2—
CH3—(CH2)3—C≡C—CH2—

015
(CH3)2N—
CH3—CH2—CH2—
CH3—(CH2)3—C≡C—CH2—

016
CH3—CH2—CH2—
CH3—CH2—CH2—
CH3—(CH2)3—C≡C—CH2—

017
(CH3)2CH—
CH3—CH2—CH2—
CH3—(CH2)3—C≡C—CH2—

018
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—
CH3—(CH2)3—C≡C—CH2—

019
CH3—

CH3—(CH2)3—C≡C—CH2—

020
CH3—CH2—

CH3—(CH2)3—C≡C—CH2—

021
(CH3)2N—

CH3—(CH2)3—C≡C—CH2—

022
CH3—CH2—CH2—

CH3—(CH2)3—C≡C—CH2—

023
(CH3)2CH—

CH3—(CH2)3—C≡C—CH2—

024
Cl—CH2—CH2—CH2—

CH3—(CH2)3—C≡C—CH2—

025
CH3—
CH2═CH—CH2—CH3—
CH3—(CH2)3—C≡C—CH2—

026
CH3—CH2—
CH2═CH—CH2—
CH3—(CH2)3—C≡C—CH2—

027
(CH3)2N—
CH2═CH—CH2—
CH3—(CH2)3—C≡C—CH2—

028
CH3—CH2—CH2—
CH2═CH—CH2—
CH3—(CH2)3—C≡C—CH2—

029
(CH3)2CH—
CH2═CH—CH2—
CH3—(CH2)3—C≡C—CH2—

030
Cl—CH2—CH2—CH2—
CH2═CH—CH2—
CH3—(CH2)3—C≡C—CH2—

031
CH3—
CH═C—CH2—
CH3—(CH2)3—C≡C—CH2—

032
CH3—CH2—
CH═C—CH2—
CH3—(CH2)3—C≡C—CH2—

033
(CH3)2N—
CH═C—CH2—
CH3—(CH2)3—C≡C—CH2—

034
CH3—CH2—CH2—
CH═C—CH2—
CH3—(CH2)3—C≡C—CH2—

035
(CH3)2CH—
CH═C—CH2—
CH3—(CH2)3—C≡C—CH2—

036
Cl—CH2—CH2—CH2—
CH═C—CH2—
CH3—(CH2)3—C≡C—CH2—

037
CH3—
CH3—CH2—CH(CH3)—
CH3—(CH2)3—C≡C—CH2—

038
CH3—CH2—
CH3—CH2—CH(CH3)—
CH3—(CH2)3—C≡C—CH2—

039
(CH3)2N—
CH3—CH2—CH(CH3)—
CH3—(CH2)3—C≡C—CH2—

040
CH3—CH2—CH2—
CH3—CH2—CH(CH3)—
CH3—(CH2)3—C≡C—CH2—

041
(CH3)2CH—
CH3—CH2—CH(CH3)—
CH3—(CH2)3—C≡C—CH2—

042
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—
CH3—(CH2)3—C≡C—CH2—

045
CH3—
CH3—CH2—

046
CH3—CH2—
CH3—CH2—

047
(CH3)2N—
CH3—CH2—

048
CH3—CH2—CH2—
CH3—CH2—

049
(CH3)2CH—
CH3—CH2—

050
Cl—CH2—CH2—CH2—
CH3—CH2—

51
CH3—
(CH3)2CH—

052
CH3—CH2—
(CH3)2CH—

053
(CH3)2N—
(CH3)2CH—

054
CH3—CH2—CH2—
(CH3)2CH—

055
(CH3)2CH—
(CH3)2CH—

056
Cl—CH2—CH2—CH2—
(CH3)2CH—

057
CH3—
CH3—CH2—CH2—

058
CH3—CH2—
CH3—CH2—CH2—

059
(CH3)2N—
CH3—CH2—CH2—

060
CH3—CH2—CH2—
CH3—CH2—CH2—

061
(CH3)2CH—
CH3—CH2—CH2—

062
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—

063
CH3—

064
CH3—CH2—

065
(CH3)2N—

066
CH3—CH2—CH2—

067
(CH3)2CH—

068
Cl—CH2—CH2—CH2—

069
CH3—
CH2═CH—CH2—

070
CH3—CH2—
CH2═CH—CH2—

071
(CH3)2N—
CH2═CH═CH2—

072
CH3—CH2—CH2—
CH2═CH—CH2—

073
(CH3)2CH—
CH2═CH—CH2—

074
Cl—CH2—CH2—CH2—
CH2═CH—CH2—

075
CH3—
CH═C—CH2—

076
CH3—CH2—
CH≡C—CH2—

077
(CH3)2N—
CH≡C—CH2—

078
CH3—CH2—CH2—
CH≡C—CH2—

079
(CH3)2CH—
CH≡C—CH2—

080
Cl—CH2—CH2—CH2—
CH≡C—CH2—

081
CH3—
CH3—CH2—CH(CH3)—

082
CH3—CH2—
CH3—CH2—CH(CH3)—

083
(CH3)2N—
CH3—CH2—CH(CH3)—

084
CH3—CH2—CH2—
CH3—CH2—CH(CH3)—

085
(CH3)2CH—
CH3—CH2—CH(CH3)—

086
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—

087
CH3—
CH3—CH2—
Ph-C≡C—CH2—

088
CH3—CH2—
CH3—CH2—
Ph-C≡C—CH2—

089
(CH3)2N—
CH3—CH2—
Ph-C≡C—CH2—

090
CH3—CH2—CH2—
CH3—CH2—
Ph-C≡C—CH2—

091
(CH3)2CH—
CH3—CH2—
Ph-C≡C—CH2—

092
Cl—CH2—CH2—CH2—
CH3—CH2—
Ph-C≡C—CH2—

093
CH3—
CH3)2CH—
Ph-C≡C—CH2—

094
CH3—CH2—
CH3)2CH—
Ph-C≡C—CH2—

095
(CH3)2N—
CH3)2CH—
Ph-C≡C—CH2—

096
CH3—CH2—CH2—
CH3)2CH—
Ph-C≡C—CH2—

097
(CH3)2CH—
CH3)2CH—
Ph-C≡C—CH2—

098
Cl—CH2—CH2—CH2—
CH3)2CH—
Ph-C≡C—CH2—

099
CH3—
CH3—CH2—CH2—
Ph-C≡C—CH2—

100
CH3—CH2—
CH3—CH2—CH2—
Ph-C≡C—CH2—

101
(CH3)2N—
CH3—CH2—CH2—
Ph-C≡C—CH2—

102
CH3—CH2—CH2—
CH3—CH2—CH2—
Ph-C≡C—CH2—

103
(CH3)2CH—
CH3—CH2—CH2—
Ph-C≡C—CH2—

104
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—
Ph-C≡C—CH2—

105
CH3—

Ph-C≡C—CH2—

106
CH3—CH2—

Ph-C≡C—CH2—

107
(CH3)2N—

Ph-C≡C—CH2—

108
CH3—CH2—CH2—

Ph-C≡C—CH2—

109
(CH3)2CH—

Ph-C≡C—CH2—

110
Cl—CH2—CH2—CH2—

Ph-C≡C—CH2—

111
CH3—
CH2═CH—CH2—
Ph-C≡C—CH2—

112
CH3—CH2—
CH2═CH—CH2—
Ph-C≡C—CH2—

113
(CH3)2N—
CH2═CH—CH2—
Ph-C≡C—CH2—

114
CH3—CH2—CH2—
CH2═CH—CH2—
Ph-C≡C—CH2—

115
(CH3)2CH—
CH2═CH—CH2—
Ph-C≡C—CH2—

116
Cl—CH2—CH2—CH2—
CH2═CH—CH2—
Ph-C≡C—CH2—

117
CH3—
CH≡C—CH2—
Ph-C≡C—CH2—

118
CH3—CH2—
CH≡C—CH2—
Ph-C≡C—CH2—

119
(CH3)2N—
CH≡C—CH2—
Ph-C≡C—CH2—

120
CH3—CH2—CH2—
CH≡C—CH2—
Ph-C≡C—CH2—

121
(CH3)2CH—
CH≡C—CH2—
Ph-C≡C—CH2—

122
Cl—CH2—CH2—CH2—
CH≡C—CH2—
Ph-C≡C—CH2—

123
CH3—
CH3—CH2—CH(CH3)—
Ph-C≡C—CH2—

124
CH3—CH2—
CH3—CH2—CH(CH3)—
Ph-C≡C—CH2—

125
(CH3)2N—
CH3—CH2—CH(CH3)—
Ph-C≡C—CH2—

126
CH3—CH2—CH2—
CH3—CH2—CH(CH3)—
Ph-C≡C—CH2—

127
(CH3)2CH—
CH3—CH2—CH(CH3)—
Ph-C≡C—CH2—

128
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—
Ph-C≡C—CH2—

129
CH3—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

130
CH3—CH2—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

131
(CH3)2N—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

132
CH3—CH2—CH2—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

133
(CH3)2CH—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

134
Cl—CH2—CH2—CH2—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

135
CH3—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

136
CH3—CH2—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

137
(CH3)2N—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

138
CH3—CH2—CH2—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

139
(CH3)2CH—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

140
Cl—CH2—CH2—CH2—
CH3—CH2—
(4-F-Ph)-C≡C—CH2—

141
CH3—
CH3—CH2—CH2—
(4-F-Ph)-C≡C—CH2—

142
CH3—CH2—
CH3—CH2—CH2—
(4-F-Ph)-C≡C—CH2—

143
(CH3)2N—
CH3—CH2—CH2—
(4-F-Ph)-C≡C—CH2—

144
CH3—CH2—CH2—
CH3—CH2—CH2—
(4-F-Ph)-C≡C—CH2—

145
(CH3)2CH—
CH3—CH2—CH2—
(4-F-Ph)-C≡C—CH2—

146
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—
(4-F-Ph)-C≡C—CH2—

147
CH3—

(4-F-Ph)-C≡C—CH2—

148
CH3—CH2—

(4-F-Ph)-C≡C—CH2—

149
(CH3)2N—

(4-F-Ph)-C≡C—CH2—

150
CH3—CH2—CH2—

(4-F-Ph)-C≡C—CH2—

151
(CH3)2CH—

(4-F-Ph)-C≡C—CH2—

152
Cl—CH2—CH2—CH2—

(4-F-Ph)-C≡C—CH2—

153
CH3—
CH2═CH—CH2—
(4-F-Ph)-C≡C—CH2—

154
CH3—CH2—
CH2═CH—CH2—
(4-F-Ph)-C≡C—CH2—

155
(CH3)2N—
CH2═CH—CH2—
(4-F-Ph)-C≡C—CH2—

156
CH3—CH2—CH2—
CH2═CH—CH2—
(4-F-Ph)-C≡C—CH2—

157
(CH3)2CH—
CH2═CH—CH2—
(4-F-Ph)-C≡C—CH2—

158
Cl—CH2—CH2—CH2—
CH2═CH—CH2—
(4-F-Ph)-C≡C—CH2—

159
CH3—
CH≡C—CH2—
(4-F-Ph)-C≡C—CH2—

160
CH3—CH2—
CH≡C—CH2—
(4-F-Ph)-C≡C—CH2—

161
(CH3)2N—
CH≡C—CH2—
(4-F-Ph)-C≡C—CH2—

162
CH3—CH2—CH2—
CH≡C—CH2—
(4-F-Ph)-C≡C—CH2—

163
(CH3)2CH—
CH≡C—CH2—
(4-F-Ph)-C≡C—CH2—

164
Cl—CH2—CH2—CH2—
CH≡C—CH2—
(4-F-Ph)-C≡C—CH2—

165
CH3—
CH3—CH2—CH(CH3)—
(4-F-Ph)-C≡C—CH2—

166
CH3—CH2—
CH3—CH2—CH(CH3)—
(4-F-Ph)-C≡C—CH2—

167
(CH3)2N—
CH3—CH2—CH(CH3)—
(4-F-Ph)-C≡C—CH2—

168
CH3—CH2—CH2—
CH3—CH2—CH(CH3)—
(4-F-Ph)-C≡C—CH2—

169
(CH3)2CH—
CH3—CH2—CH(CH3)—
(4-F-Ph)-C≡C—CH2—

170
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—
(4-F-Ph)-C≡C—CH2—

171
CH3—
CH3—CH2—
(4-Cl-Ph)-C≡C—CH2—

172
CH3—CH2—
CH3—CH2—
(4-Cl-Ph)-C≡C—CH2—

173
(CH3)2N—
CH3—CH2—
(4-Cl-Ph)-C≡C—CH2—

174
CH3—CH2—CH2—
CH3—CH2—
(4-Cl-Ph)-C≡C—CH2—

175
(CH3)2CH—
CH3—CH2—
(4-Cl-Ph)-C≡C—CH2—

176
Cl—CH2—CH2—CH2—
CH3—CH2—
(4-Cl-Ph)-C≡C—CH2—

177
CH3—
(CH3)2CH—
(4-Cl-Ph)-C≡C—CH2—

178
CH3—CH2—
(CH3)2CH—
(4-Cl-Ph)-C≡C—CH2—

179
(CH3)2N—
(CH3)2CH—
(4-Cl-Ph)-C≡C—CH2—

180
CH3—CH2—CH2—
(CH3)2CH—
(4-Cl-Ph)-C≡C—CH2—

181
(CH3)2CH—
(CH3)2CH—
(4-Cl-Ph)-C≡C—CH2—

182
Cl—CH2—CH2—CH2—
(CH3)2CH—
(4-Cl-Ph)-C≡C—CH2—

183
CH3—
CH3—CH2—CH2—
(4-Cl-Ph)-C≡C—CH2—

184
CH3—CH2—
CH3—CH2—CH2—
(4-Cl-Ph)-C≡C—CH2—

185
(CH3)2N—
CH3—CH2—CH2—
(4-Cl-Ph)-C≡C—CH2—

186
CH3—CH2—CH2—
CH3—CH2—CH2—
(4-Cl-Ph)-C≡C—CH2—

187
(CH3)2CH—
CH3—CH2—CH2—
(4-Cl-Ph)-C≡C—CH2—

188
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—
(4-Cl-Ph)-C≡C—CH2—

189
CH3—

(4-Cl-Ph)-C≡C—CH2—

190
CH3—CH2—

(4-Cl-Ph)-C≡C—CH2—

191
(CH3)2N—

(4-Cl-Ph)-C≡C—CH2—

192
CH3—CH2—CH2—

(4-Cl-Ph)-C≡C—CH2—

193
(CH3)2CH—

(4-Cl-Ph)-C≡C—CH2—

194
Cl—CH2—CH2—CH2—

(4-Cl-Ph)-C≡C—CH2—

195
CH3—
CH2═CH—CH2—
(4-Cl-Ph)-C≡C—CH2—

196
CH3—CH2—
CH2═CH—CH2—
(4-Cl-Ph)-C≡C—CH2—

197
(CH3)2N—
CH2═CH—CH2—
(4-Cl-Ph)-C≡C—CH2—

198
CH3—CH2—CH2—
CH2═CH—CH2—
(4-Cl-Ph)-C≡C—CH2—

199
(CH3)2CH—
CH2═CH—CH2—
(4-Cl-Ph)-C≡C—CH2—

200
Cl—CH2—CH2CH2—
CH2═CH—CH2—
(4-Cl-Ph)-C≡C—CH2—

201
CH3—
CH≡C—CH2—
(4-Cl-Ph)-C≡C—CH2—

202
CH3—CH2—
CH≡C—CH2—
(4-Cl-Ph)-C≡C—CH2—

203
(CH3)2N—
CH≡C—CH2—
(4-Cl-Ph)-C≡C—CH2—

204
CH3—CH2—CH2—
CH≡C—CH2—
(4-Cl-Ph)-C≡C—CH2—

205
(CH3)2CH—
CH≡C—CH2—
(4-Cl-Ph)-C≡C—CH2—

206
Cl—CH2—CH2—CH2—
CH≡C—CH2—
(4-Cl-Ph)-C≡C—CH2—

207
CH3—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-C≡C—CH2—

208
CH3—CH2—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-C≡C—CH2—

209
(CH3)2N—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-C≡C—CH2—

210
CH3—CH2—CH2—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-C≡C—CH2—

211
(CH3)2CH—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-C≡C—CH2—

212
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-C≡C—CH2—

213
CH3—
CH3—CH2—
(4-Br-Ph)-C≡C—CH2—

214
CH3—CH2—
CH3—CH2—
(4-Br-Ph)-C≡C—CH2—

215
(CH3)2N—
CH3—CH2—
(4-Br-Ph)-C≡C—CH2—

216
CH3—CH2—CH2—
CH3—CH2—
(4-Br-Ph)-C≡C—CH2—

217
(CH3)2CH—
CH3—CH2—
(4-Br-Ph)-C≡C—CH2—

218
Cl—CH2—CH2—CH2—
CH3—CH2—
(4-Br-Ph)-C≡C—CH2—

219
CH3—
(CH3)2CH—
(4-Br-Ph)-C≡C—CH2—

220
CH3—CH2—
(CH3)2CH—
(4-Br-Ph)-C≡C—CH2—

221
(CH3)2N—
(CH3)2CH—
(4-Br-Ph)-C≡C—CH2—

222
CH3—CH2—CH2—
(CH3)2CH—
(4-Br-Ph)-C≡C—CH2—

223
(CH3)2CH—
(CH3)2CH—
(4-Br-Ph)-C≡C—CH2—

224
Cl—CH2—CH2—CH2—
(CH3)2CH—
(4-Br-Ph)-C≡C—CH2—

225
CH3—
CH3—CH2—CH2—
(4-Br-Ph)-C≡C—CH2—

226
CH3—CH2—
CH3—CH2—CH2—
(4-Br-Ph)-C≡C—CH2—

227
(CH3)2N—
CH3—CH2—CH2—
(4-Br-Ph)-C≡C—CH2—

228
CH3—CH2—CH2—
CH3—CH2—CH2—
(4-Br-Ph)-C≡C—CH2—

229
(CH3)2CH—
CH3—CH2—CH2—
(4-Br-Ph)-C≡C—CH2—

230
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—
(4-Br-Ph)-C≡C—CH2—

231
CH3—

(4-Br-Ph)-C≡C—CH2—

232
CH3—CH2—

(4-Br-Ph)-C≡C—CH2—

233
(CH3)2N—

(4-Br-Ph)-C≡C—CH2—

234
CH3—CH2—CH2—

(4-Br-Ph)-C≡C—CH2—

235
(CH3)2CH—

(4-Br-Ph)-C≡C—CH2—

236
Cl—CH2—CH2—CH2—

100

(4-Br-Ph)-C≡C—CH2—

237
CH3—
CH2═CH—CH2—
(4-Br-Ph)-C≡C—CH2—

238
CH3—CH2—
CH2═CH—CH2—
(4-Br-Ph)-C≡C—CH2—

239
(CH3)2N—
CH2═CH—CH2—
(4-Br-Ph)-C≡C—CH2—

240
CH3—CH2—CH2—
CH2═CH—CH2—
(4-Br-Ph)-C≡C—CH2—

241
(CH3)2CH—
CH2═CH—CH2—
(4-Br-Ph)-C≡C—CH2—

242
Cl—CH2—CH2—CH2—
CH2═CH—CH2—
(4-Br-Ph)-C≡C—CH2—

243
CH3—
CH≡C—CH2—
(4-Br-Ph)-C≡C—CH2—

244
CH3—CH2—
CH≡C—CH2—
(4-Br-Ph)-C≡C—CH2—

245
(CH3)2N—
CH≡C—CH2—
(4-Br-Ph)-C≡C—CH2—

246
CH3—CH2—CH2—
CH≡C—CH2—
(4-Br-Ph)-C≡C—CH2—

247
(CH3)2CH—
CH≡C—CH2—
(4-Br-Ph)-C≡C—CH2—

248
Cl—CH2—CH2—CH2—
CH≡C—CH2—
(4-Br-Ph)-C≡C—CH2—

249
CH3—
CH3—CH2—CH(CH3)—
(4-Br-Ph)-C≡C—CH2—

250
CH3—CH2—
CH3—CH2—CH(CH3)—
(4-Br-Ph)-C≡C—CH2—

251
(CH3)2N—
CH3—CH2—CH(CH3)—
(4-Br-Ph)-C≡C—CH2—

252
CH3—CH2—CH2—
CH3—CH2—CH(CH3)—
(4-Br-Ph)-C≡C—CH2—

253
(CH3)2CH—
CH3—CH2—CH(CH3)—
(4-Br-Ph)-C≡C—CH2—

254
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—
(4-Br-Ph)-C≡C—CH2—

255
CH3—
CH3—CH2—
H

256
CH3—CH2—
CH3—CH2—
H

257
(CH3)2N—
CH3—CH2—
H

258
CH3—CH2—CH2—
CH3—CH2—
H

259
(CH3)2CH—
CH3—CH2—
H

260
Cl—CH2—CH2—CH2—
CH3—CH2—
H

261
CH3—
(CH3)2CH—
H

262
CH3—CH2—
(CH3)2CH—
H

263
(CH3)2N—
(CH3)2CH—
H

264
CH3—CH2—CH2—
(CH3)2CH—
H

265
(CH3)2CH—
(CH3)2CH—
H

266
Cl—CH2—CH2—CH2—
(CH3)2CH—
H

267
CH3—
CH3—CH2—CH2—
H

268
CH3—CH2—
CH3—CH2—CH2—
H

269
(CH3)2N—
CH3—CH2—CH2—
H

270
CH3—CH2—CH2—
CH3—CH2—CH2—
H

271
(CH3)2CH—
CH3—CH2—CH2—
H

272
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—
H

273
CH3—

101

H

274
CH3—CH2—

102

H

275
(CH3)2N—

103

H

276
CH3—CH2—CH2—

104

H

277
(CH3)2CH—

105

H

278
Cl—CH2—CH2—CH2—

106

H

279
CH3—
CH2═CH—CH2—
H

280
CH3—CH2—
CH2═CH—CH2—
H

281
(CH3)2N—
CH2═CH—CH2—
H

282
CH3—CH2—CH2—
CH2═CH—CH2—
H

283
(CH3)2CH—
CH2═CH—CH2—
H

284
Cl—CH2—CH2—CH2—
CH2═CH—CH2—
H

285
CH3—
CH≡C—CH2—
H

286
CH3—CH2—
CH≡C—CH2—
H

287
(CH3)2N—
CH≡C—CH2—
H

288
CH3—CH2—CH2—
CH≡C—CH2—
H

289
(CH3)2CH—
CH≡C—CH2—
H

290
Cl—CH2—CH2—CH2—
CH≡C—CH2—
H

291
CH3—
CH3—CH2—CH(CH3)—
H

292
CH3—CH2—
CH3—CH2—CH(CH3)—
H

293
(CH3)2N—
CH3—CH2—CH(CH3)—
H

294
CH3—CH2—CH2—
CH3—CH2—CH(CH3)—
H

295
(CH3)2CH—
CH3—CH2—CH(CH3)—
H

296
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—
H

297
CH3—
CH3—CH2—
Ph-CH2—

298
CH3—CH2—
CH3—CH2—
Ph-CH2—

299
(CH3)2N—
CH3—CH2—
Ph-CH2—

300
CH3—CH2—CH2—
CH3—CH2—
Ph-CH2—

301
(CH3)2CH—
CH3—CH2—
Ph-CH2—

302
Cl—CH2—CH2—CH2—
CH3—CH2—
Ph-CH2—

303
CH3—
(CH3)2CH—
Ph-CH2—

304
CH3—CH2—
(CH3)2CH—
Ph-CH2—

305
(CH3)2N—
(CH3)2CH—
Ph-CH2—

306
CH3—CH2—CH2—
(CH3)2CH—
Ph-CH2—

307
(CH3)2CH—
(CH3)2CH—
Ph-CH2—

308
Cl—CH2—CH2—CH2—
(CH3)2CH—
Ph-CH2—

309
CH3—
CH3—CH2—CH2—
Ph-CH2—

310
CH3—CH2—
CH3—CH2—CH2—
Ph-CH2—

311
(CH3)2N—
CH3—CH2—CH2—
Ph-CH2—

312
CH3—CH2—CH2—
CH3—CH2—CH2—
Ph-CH2—

313
(CH3)2CH—
CH3—CH2—CH2—
Ph-CH2—

314
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—
Ph-CH2—

315
CH3—

107

Ph-CH2—

316
CH3—CH2—

108

Ph-CH2—

317
(CH3)2N—

109

Ph-CH2—

318
CH3—CH2—CH2—

110

Ph-CH2—~

319
(CH3)2CH—

111

Ph-CH2—

320
Cl—CH2—CH2—CH2—

112

Ph-CH2—

321
CH3—
CH2═CH—CH2—
Ph-CH2—

322
CH3—CH2—
CH2═CH—CH2—
Ph-CH2—

323
(CH3)2N—
CH2═CH—CH2—
Ph-CH2—

324
CH3—CH2—CH2—
CH2═CH—CH2—
Ph-CH2—

325
(CH3)2CH—
CH2═CH—CH2—
Ph-CH2—

326
Cl—CH2—CH2—CH2—
CH2═CH—CH2—
Ph-CH2—

327
CH3—
CH≡C—CH2—
Ph-CH2—

328
CH3—CH2—
CH≡C—CH2—
Ph-CH2—

329
(CH3)2N—
CH≡C—CH2—
Ph-CH2—

330
CH3—CH2—CH2—
CH≡C—CH2—
Ph-CH2—

331
(CH3)2CH—
CH≡C—CH2—
Ph-CH2—

332
Cl—CH2—CH2—CH2—
CH≡C—CH2—
Ph-CH2—

333
CH3—
CH3—CH2—CH(CH3)—
Ph-CH2—

334
CH3—CH2—
CH3—CH2—CH(CH3)—
Ph-CH2—

335
(CH3)2N—
CH3—CH2—CH(CH3)—
Ph-CH2—

336
CH3—CH2—CH2—
CH3—CH2—CH(CH3)—
Ph-CH2—

337
(CH3)2CH—
CH3—CH2—CH(CH3)—
Ph-CH2—

338
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—
Ph-CH2—

339
CH3—
CH3—CH2—
(4-Cl-Ph)-CH2—

340
CH3—CH2—
CH3—CH2—
(4-Cl-Ph)-CH2—

341
(CH3)2N—
CH3—CH2—
(4-Cl-Ph)-CH2—

342
CH3—CH2—CH2—
CH3—CH2—
(4-Cl-Ph)-CH2—

343
(CH3)2CH—
CH3—CH2—
(4-Cl-Ph)-CH2—

344
Cl—CH2—CH2—CH2—
CH3—CH2—
(4-Cl-Ph)-CH2—

345
CH3—
(CH3)2CH—
(4-Cl-Ph)-CH2—

346
CH3—CH2—
(CH3)2CH—
(4-Cl-Ph)-CH2—

347
(CH3)2N—
(CH3)2CH—
(4-Cl-Ph)-CH2—

348
CH3—CH2—CH2—
(CH3)2CH—
(4-Cl-Ph)-CH2—

349
(CH3)2CH—
(CH3)2CH—
(4-Cl-Ph)-CH2—

350
Cl—CH2—CH2—CH2—
(CH3)2CH—
(4-Cl-Ph)-CH2—

351
CH3—
CH3—CH2—CH2—
(4-Cl-Ph)-CH2—

352
CH3—CH2—
CH3—CH2—CH2—
(4-Cl-Ph)-CH2—

353
(CH3)2N—
CH3—CH2—CH2—
(4-Cl-Ph)-CH2—

354
CH3—CH2—CH2—
CH3—CH2—CH2—
(4-Cl-Ph)-CH2—

355
(CH3)2CH—
CH3—CH2—CH2—
(4-Cl-Ph)-CH2—

356
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—
(4-Cl-Ph)-CH2—

357
CH3—

113

(4-Cl-Ph)-CH2—

358
CH3—CH2—

114

(4-Cl-Ph)-CH2—

359
(CH3)2N—

115

(4-Cl-Ph)-CH2—

360
CH3—CH2—CH2—

116

(4-Cl-Ph)-CH2—

361
(CH3)2CH—

117

(4-Cl-Ph)-CH2—

362
Cl—CH2—CH2—CH2—

118

(4-Cl-Ph)-CH2—

363
CH3—
CH2═CH—CH2—
(4-Cl-Ph)-CH2—

364
CH3—CH2—
CH2═CH—CH2—
(4-Cl-Ph)-CH2—

365
(CH3)2N—
CH2═CH—CH2—
(4-Cl-Ph)-CH2—

366
CH3—CH2—CH2—
CH2═CH—CH2—
(4-Cl-Ph)-CH2—

367
(CH3)2CH—
CH2═CH—CH2—
(4-Cl-Ph)-CH2—

368
Cl—CH2—CH2—CH2—
CH2═CH—CH2—
(4-Cl-Ph)-CH2—

369
CH3—
CH≡C—CH2—
(4-Cl-Ph)-CH2—

370
CH3—CH2—
CH≡C—CH2—
(4-Cl-Ph)-CH2—

371
(CH3)2N—
CH≡C—CH2—
(4-Cl-Ph)-CH2—

372
CH3—CH2—CH2—
CH≡C—CH2—
(4-Cl-Ph)-CH2—

373
(CH3)2CH—
CH≡C—CH2—
(4-Cl-Ph)-CH2—

374
Cl—CH2—CH2—CH2—
CH≡C—CH2—
(4-Cl-Ph)-CH2—

375
CH3—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-CH2—

376
CH3—CH2—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-CH2—

378
(CH3)2N—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-CH2—

379
CH3—CH2—CH2—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-CH2—

380
(CH3)2CH—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-CH2—

381
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—
(4-Cl-Ph)-CH2—

382
CH3—
CH3—CH2—
(3-Cl-Ph)-CH2—

383
CH3—CH2—
CH3—CH2—
(3-Cl-Ph)-CH2—

384
(CH3)2N—
CH3—CH2—
(3-Cl-Ph)-CH2—

385
CH3—CH2—CH2—
CH3—CH2—
(3-Cl-Ph)-CH2—

386
(CH3)2CH—
CH3—CH2—
(3-Cl-Ph)-CH2—

387
Cl—CH2—CH2—CH2—
CH3—CH2—
(3-Cl-Ph)-CH2—

388
CH3—
(CH3)2CH—
(3-Cl-Ph)-CH2—

389
CH3—CH2—
(CH3)2CH—
(3-Cl-Ph)-CH2—

390
(CH3)2N—
(CH3)2CH—
(3-Cl-Ph)-CH2—

391
CH3—CH2—CH2—
(CH3)2CH—
(3-Cl-Ph)-CH2—

392
(CH3)2CH—
(CH3)2CH—
(3-Cl-Ph)-CH2—

393
Cl—CH2—CH2—CH2—
(CH3)2CH—
(3-Cl-Ph)-CH2—

394
CH3—
CH3—CH2—CH2—
(3-Cl-Ph)-CH2—

395
CH3—CH2—
CH3—CH2—CH2—
(3-Cl-Ph)-CH2—

396
(CH3)2N—
CH3—CH2—CH2—
(3-Cl-Ph)-CH2—

397
CH3—CH2—CH2—
CH3—CH2—CH2—
(3-Cl-Ph)-CH2—

398
(CH3)2CH—
CH3—CH2—CH2—
(3-Cl-Ph)-CH2—

399
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—
(3-Cl-Ph)-CH2—

400
CH3—

119

(3-Cl-Ph)-CH2—

401
CH3—CH2—

120

(3-Cl-Ph)-CH2—

402
(CH3)2N—

121

(3-Cl-Ph)-CH2—

403
CH3-CH2—CH2—

122

(3-Cl-Ph)-CH2—

404
(CH3)2CH—

123

(3-Cl-Ph)-CH2—

405
Cl—CH2—CH2—CH2—

124

(3-Cl-Ph)-CH2—

406
CH3—
CH2═CH—CH2—
(3-Cl-Ph)-CH2—

407
CH3—CH2—
CH2═CH—CH2—
(3-Cl-Ph)-CH2—

408
(CH3)2N—
CH2═CH—CH2—
(3-Cl-Ph)-CH2—

409
CH3—CH2—CH2—
CH2═CH—CH2—
(3-Cl-Ph)-CH2—

410
(CH3)2CH—
CH2═CH—CH2—
(3-Cl-Ph)-CH2—

411
Cl—CH2—CH2—CH2—
CH2═CH—CH2—
(3-Cl-Ph)-CH2—

412
CH3—
CH≡C—CH2—
(3-Cl-Ph)-CH2—

413
CH3—CH2—
CH≡C—CH2—
(3-Cl-Ph)-CH2—

414
(CH3)2N—
CH≡C—CH2—
(3-Cl-Ph)-CH2—

415
CH3—CH2—CH2—
CH≡C—CH2—
(3-Cl-Ph)-CH2—

416
(CH3)2CH—
CH≡C—CH2—
(3-Cl-Ph)-CH2—

417
Cl—CH2—CH2—CH2—
CH≡C—CH2—
(3-Cl-Ph)-CH2—

418
CH3—
CH3—CH2—CH(CH3)—
(3-Cl-Ph)-CH2—

419
CH3—CH2—
CH3—CH2—CH(CH3)—
(3-Cl-Ph)-CH2—

420
(CH3)2N—
CH3—CH2—CH(CH3)—
(3-Cl-Ph)-CH2—

421
CH3—CH2—CH2—
CH3—CH2—
CH(CH3)—(3-Cl-Ph)-CH2—

422
(CH3)2CH—
CH3—CH2—CH(CH3)—
(3-Cl-Ph)-CH2—

423
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—
(3-Cl-Ph)-CH2—

424
CH3—
CH3—CH2—
(3-CF3-Ph)-CH2—

425
CH3—CH2—
CH3—CH2—
(3-CF3-Ph)-CH2—

426
(CH3)2N—
CH3—CH2—
(3-CF3-Ph)-CH2—

427
CH3—CH2—CH2—
CH3—CH2—
(3-CF3-Ph)-CH2—

428
(CH3)2CH—
CH3—CH2—
(3-CF3-Ph)-CH2—

429
Cl—CH2—CH2—CH2—
CH3—CH2—
(3-CF3-Ph)-CH2—

430
CH3—
(CH3)2CH—
(3-CF3-Ph)-CH2—

431
CH3—CH2—
(CH3)2CH—
(3-CF3-Ph)-CH2—

432
(CH3)2N—
(CH3)2CH—
(3-CF3-Ph)-CH2—

433
CH3—CH2—CH2—
(CH3)2CH—
(3-CF3-Ph)-CH2—

434
(CH3)2CH—
(CH3)2CH—
(3-CF3-Ph)-CH2—

435
Cl—CH2—CH2—
(CH3)2CH—
(3-CF3-Ph)-CH2—

436
CH3—
CH3—CH2—CH2—
(3-CF3-Ph)-CH2—

437
CH3—CH2—
CH3—CH2—CH2—
(3-CF3-Ph)-CH2—

438
(CH3)2N—
CH3—CH2—CH2—
(3-CF3-Ph)-CH2—

439
CH3—CH2—CH2—
CH3—CH2—CH2—
(3-CF3-Ph)-CH2—

440
(CH3)2CH—
CH3—CH2—CH2—
(3-CF3-Ph)-CH2—

441
Cl—CH2—CH2—CH2—
CH3—CH2—CH2—
(3-CF3-Ph)-CH2—

442
CH3—

125

(3-CF3-Ph)-CH2—

443
CH3—CH2—

126

(3-CF3-Ph)-CH2—

444
(CH3)2N—

127

(3-CF3-Ph)-CH2—

445
CH3—CH2—CH2—

128

(3-CF3-Ph)-CH2—

446
(CH3)2CH—

129

(3-CF3-Ph)-CH2—

447
Cl—CH2—CH2—CH2—

130

(3-CF3-Ph)-CH2—

448
CH3—
CH2═CH—CH2—
(3-CF3-Ph)-CH2—

449
CH3—CH2—
CH2═CH—CH2—
(3-CF3-Ph)-CH2—

450
(CH3)2N—
CH2═CH—CH2—
(3-CF3-Ph)-CH2—

451
CH3—CH2—CH2—
CH2═CH—CH2—
(3-CF3-Ph)-CH2—

452
(CH3)2CH—
CH2═CH—CH2—
(3-CF3-Ph)-CH2—

453
Cl—CH2—CH2—CH2—
CH2═CH—CH2—
(3-CF3-Ph)-CH2—

454
CH3—
CH≡C—CH2—
(3-CF3-Ph)-CH2—

455
CH3—CH2—
CH≡C—CH2—
(3-CF3-Ph)-CH2—

456
(CH3)2N—
CH≡C—CH2—
(3-CF3-Ph)-CH2—

457
CH3—CH2—CH2—
CH≡C—CH2—
(3-CF3-Ph)-CH2—

458
(CH3)2CH—
CH≡C—CH2—
(3-CF3-Ph)-CH2—

459
Cl—CH2—CH2—CH2—
CH═C—CH2—
(3-CF3-Ph)-CH2—

460
CH3—
CH3—CH2—CH(CH3)—
(3-CF3-Ph)-CH2—

461
CH3—CH2—
CH3—CH2—CH(CH3)—
(3-CF3-Ph)-CH2—

462
(CH3)2N—
CH3—CH2—CH(CH3)—
(3-CF3-Ph)-CH2—

463
CH3—CH2—CH2—
CH3—CH2—CH(CH3)—
(3-CF3-Ph)-CH2—

464
(CH3)2CH—
CH3—CH2—CH(CH3)—
(3-CF3-Ph)-CH2—

465
Cl—CH2—CH2—CH2—
CH3—CH2—CH(CH3)—
(3-CF3-Ph)-CH2—

[0166]

11

TABLE 7

Compounds represented by the Formula 1.7 where the combination of the groups

R1, and R3 corresponds to each row in table B.

I.7

131

[0167]

12

TABLE 8

Compounds represented by the Formula I.8 where the combination of

the groups R1, and R3 corresponds to each row in table B.

132

I.8

[0168]

13

TABLE 9

Compounds represented by the Formula I.9 where the combination of

the groups R1, and R3 corresponds to each row in table B.

133

I.9

[0169]

14

TABLE 10

Compounds represented by the Formula I.10 where the combination of

the groups R1, and R3 corresponds to each row in table B.

134

I.10

[0170]

15

TABLE 11

Compounds represented by the Formula I.11 where the combination of

the groups R1, and R3 corresponds to each row in table B.

135

I.11

[0171]

16

TABLE 12

Compounds represented by the Formula 1.12 where the

combination of the groups R1, and R3

corresponds to each row in table B.

1.12

136

[0172]

17

TABLE B

No.
R1
R3

001
(CH3—CH2)2N—
CH3—CH2—

002
CH3—CH2—(CH3)N—
CH3—CH2—

003

137

CH3—CH2—

004
CH3—(CH2)2—CH2—
CH3—CH2—

005
(CH3)2CH—CH2—
CH3—CH2—

006
CH3—CH2—(CH3)CH—
CH3—CH2—

007
(CH3)3C—
CH3—CH2—

008
CH2═CH—
CH3—CH2—

009

138

CH3—CH2—

010
(CH3—CH2)2N—
(CH3)2CH—

011
CH3—CH2—(CH3)N—
(CH3)2CH—

012

139

(CH3)2CH—

013
CH3—(CH2)2—CH2—
(CH3)2CH—

014
(CH3)2CH—CH2—
(CH3)2CH—

015
CH3—CH2—(CH3)CH—
(CH3)2CH—

016
(CH3)3C—
(CH3)2CH—

017
CH2═CH—
(CH3)2CH—

018

140

(CH3)2CH—

019
(CH3—CH2)2N—
CH3—CH2—CH2

020
CH3—CH2—(CH3)N—
CH3—CH2—CH2

021

141

CH3—CH2—CH2

022
CH3—(CH2)2—CH2—
CH3—CH2—CH2

023
(CH3)2CH—CH2—
CH3—CH2—CH2

024
CH3—CH2—(CH3)CH—
CH3—CH2—CH2

025
(CH3)3C—
CH3—CH2—CH2

026
CH2═CH—
CH3—CH2—CH2

027

142

CH3—CH2—CH2

028
(CH3—CH2)2N—
CH3—CH2—(CH3)CH—

029
CH3—CH2—(CH3)N—
CH3—CH2—(CH3)CH—

030

143

CH3—CH2—(CH3)CH—

031
CH3—(CH2)2—CH2—
CH3—CH2—(CH3)CH—

032
(CH3)2CH—CH2—
CH3—CH2—(CH3)CH—

033
CH3—CH2—(CH3)CH—
CH3—CH2—(CH3)CH—

034
(CH3)3C—
CH3—CH2—(CH3)CH—

035
CH2═CH—
CH3—CH2—(CH3)CH—

036

144

CH3—CH2—(CH3)CH—

037
(CH3—CH2)2N—

145

038
CH3—CH2—(CH3)N—

146

039

147

148

040
CH3(CH2)2—CH2—

149

041
(CH3)2CH—CH2—

150

042
CH3—CH2—(CH3)CH—

151

043
(CH3)3C—

152

044
CH2═CH—

153

045

154

155

046
CH3—
HO—CH2—

047
CH3—CH2—
HO—CH2—

048
(CH3)2N—
HO—CH2—

049
CH3—CH2—CH2—
HO—CH2—

050
(CH3)2CH—
HO—CH2—

051
CH3—CH2—(CH3)CH—
HO—CH2—

052
CH3—
HO—(CH3)CH—

053
CH3—CH2—
HO—(CH3)CH—

054
(CH3)2N—
HO—(CH3)CH—

055
CH3—CH2—CH2—
HO—(CH3)CH—

056
(CH3)2CH—
HO—(CH3)CH—

057
CH3—CH2—(CH3)CH—
HO—(CH3)CH—

058
CH3—
(CH3)3C—O—(CH3)CH—

059
CH3—CH2—
(CH3)3C—O—(CH3)CH—

060
(CH3)2N—
(CH3)3C—O—(CH3)CH—

061
CH3—CH2—CH2—
(CH3)3C—O—(CH3)CH—

062
(CH3)2CH—
(CH3)3C—O—(CH3)CH—

063
CH3—CH2—(CH3)CH—
(CH3)3C—O—(CH3)CH—

064
CH3—
CH3—S—CH2—CH2—

065
CH3—CH2—
CH3—S—CH2—CH2—

066
(CH3)2N—
CH3—S—CH2—CH2—

067
CH3—CH2—CH2—
CH3—S—CH2—CH2—

068
(CH3)2CH—
CH3—S—CH2—CH2—

069
CH3—CH2—(CH3)CH—
CH3—S—CH2—CH2—

070
CH3—
HS—CH2—CH2—

071
CH3—CH2—
HS—CH2—CH2—

072
(CH3)2N—
HS—CH2—CH2—

073
CH3—CH2—CH2—
HS—CH2—CH2—

074
(CH3)2CH—
HS—CH2—CH2—

075
CH3—CH2—(CH3)CH—
HS—CH2—CH2—

076
CH3—
(CH3)3C—

077
CH3—CH2—
(CH3)3C—

078
(CH3)2N—
(CH3)3C—

079
CH3—CH2—CH2—
(CH3)3C—

080
(CH3)2CH—
(CH3)3C—

081
CH3—CH2—(CH3)CH—
(CH3)3C—

[0173]

18

TABLE 13

Compounds represented by the Formula I.13 where the combination of

the group R8 corresponds to each row in table C.

156

I.13

[0174]

19

TABLE 14

Compounds represented by the Formula I.14 where the combination of

the group R8 corresponds to each row in table C.

157

I.14

[0175]

20

TABLE 15

Compounds represented by the Formula 1.15 where the combination

of the group R8 corresponds to each row in table C.

1.15

158

[0176]

21

TABLE C

No.
R8

001
CH3—CH2—C(CH3)H—C≡C—CH2—

002
(CH3)3C—C≡C—CH2—

003
(CH3)2CH—CH2—C≡C—CH2—

004
CH3—(CH2)4—C≡C—CH2—

005

159

006

160

007
(4-CH3-Ph)-C≡C—CH2—

008
(2-Cl-Ph)-C≡C—CH2—

009
(3-Cl-Ph)-C≡C—CH2—

010
(3-Br-Ph)-C≡C—CH2—

012
(3-CH3-Ph)-C≡C—CH2—

013
(2,4-di-Cl-Ph)-C≡C—CH2—

014
(3,4-di-Cl-Ph)-C≡C—CH2—

015
(3,4-di-F-Ph)-C≡C—CH2—

016
(3-CH3-4-Cl-Ph)-C≡C—CH2—

017
(3-CH3-4-Br-Ph)-C≡C—CH2—

018
(3-CF3-Ph)-C≡C—CH2—

019
(4-CF3O-Ph)-C≡C—CH2—

020
(4-Et-Ph)-C≡C—CH2—

021
[4-(CH3)3C-Ph]-C≡C—CH2—

022
(4-CH2═CH-Ph)-C≡C—CH2—

023
(4-CH≡C-Ph)-C≡C—CH2—

024
(4-CH3—CO-Ph)-C≡C—CH2—

025
(4-CH3OOC-Ph)-C≡C—CH2—

026
(4-CH3O-Ph)-C≡C—CH2—

027

161

028

162

029

163

030

164

031
Ph-(CH3)CH—

032
Ph-(CH3)2C—

033
(3-F-Ph)-CH2—

034
(4-Br-Ph)-CH2—

035
(4-J-Ph)-CH2—

036
(4-CH3-Ph)-CH2—

037
(4-CH3O-Ph)-CH2—

038
(4-CF3O-Ph)-CH2—

039
(4-F-Ph)-CH2—

040
(2,4-di-F-Ph)-CH2—

041
(3,4-di-F-Ph)-CH2—

042
(3,4-di-Br-Ph)-CH2—

043
(3,4-di-Cl-Ph)-CH2—

044
(3-Cl-4-CH3-Ph)-CH2—

045
(3-CH3—4-Cl-Ph)-CH2—

046
(2,4,5-tri-Cl-Ph)-CH2—

047

165

048

166

049

167

050

168

051

169

052

170

053

171

054

172

055

173

056

174

057
Ph-CH═CH—CH2—

058
(4-Cl-Ph)-CH═CH—CH2—

059
(4-F-Ph)-CH═CH—CH2—

060
(4-Br-Ph)-CH═CH—CH2—

061
(3-CF3-Ph)-CH═CH2—

062
Ph-CH2—CH2—

063
Ph-(CH2)2—CH2—

064
(4-Cl-Ph)-(CH2)2—CH2—

065
(4-Br-Ph)-(CH2)2—CH2—

066
Ph-O—CH2—CH2—

067
(4-Cl-Ph)-O—CH2—CH2—

068
(4-F-Ph)-O—CH2—CH2—

069
(4-Br-Ph)-O—CH2—CH2—

070
(3-F-Ph)-O—CH2—CH2—

071
(3,4-di-Cl-Ph)-O—CH2—CH2—

072
(4-Cl-Ph)-O—(CH3)CH—CH2—

073
(3,4-di-Cl-Ph)-O—(CH3)CH—CH2—

074
Ph-N(CH3)—CH2—CH2—

075
Ph-N(CH2—CH3)—CH2—CH2—

076
Ph-S—CH2—CH2—

077
(4-Cl-Ph)-S—CH2—CH2—

[0177] Formulations may be prepared analogously to those described in, for example, WO 95/30651.

Biological Examples

D-1: Action Against Plasmopara viticola (Downy Mildew) on Vines

[0178] 5 week old grape seedlings cv. Gutedel are treated with the formulated test compound in a spray chamber. One day after application grape plants are inoculated by spraying a sporangia suspension (4×104 sporangia/ml) on the lower leaf side of the test plants. After an incubation period of 6 days at +21° C. and 95% r. h. in a greenhouse the disease incidence is assessed. Compounds of Tables 1 to 15 exhibit a good fungicidal action against Plasmopara viticola on vines. Compounds A1.1, A1.2, A1.3, A1.4, A1.5 and A1.6 at 200 ppm inhibit fungal infestation in this test to a least 80%, while under the same conditions untreated control plants are infected by the phytopathogenic fungi to over 80%.

D-2: Action Against Phytophthora (Late Blight) on Tomato Plants

[0179] 3 week old tomato plants cv. Roter Gnom are treated with the formulated test compound in a spray chamber. Two day after application the plants are inoculated by spraying a sporangia suspension (2×104 sporangia/mI) on the test plants. After an incubation period of 4 days at +18° C. and 95% r. h. in a growth chamber the disease incidence is assessed. Compounds of Tables 1 to 15 exhibit a long-lasting effect against fungus infestation. Compounds A1.1, A1.2, A1.3, A1.4, A1.5 and A1.6 at 200 ppm inhibit fungal infestation in this test to a least 80%, while under the same conditions untreated control plants are infected by the phytopathogenic fungi to over 80%.

D-3: Action Against Phytophthora (Late Blight) on Potato Plants

[0180] 5 week old potato plants cv. Bintje are treated with the formulated test compound in a spray chamber. Two day after application the plants are inoculated by spraying a sporangia suspension (14×104 sporangia/ml) on the test plants. After an incubation period of 4 days at +18° C. and 95% r. h. in a growth chamber the disease incidence is assessed. Fungal infestation is effectively controlled with compounds of Tables 1 to 15. Compounds A1.1, A1.2, A1.3, A1.4, A1.5 and A1.6 at 200 ppm inhibit fungal infestation in this test to a least 80%, while under the same conditions untreated control plants are infected by the phytopathogenic fungi to over 80%.

Novel alpha-sulfin and alpha-sulfonamino amide derivatives

Information

Publication Number

Date Filed

Date Published

Inventors

CPC

US Classifications

International Classifications

Abstract

Description

Claims

Priority Claims (1)

PCT Information